The interferon response to bacterial and viral infections

Abstract

Type I interferons (IFNs) were first described several decades ago as soluble factors that were capable of `interfering' with viral replication when added to infected cells. Type I IFNs have been shown to be induced by recognition of viral DNA and RNA via three distinct pathways: (i) a TRIFdependent pathway in macrophages via TLRs 3 and 4; (ii) a MyD88-dependent pathway in plasmacytoid dendritic cells (pDCs) via TLRs 7/8 and 9; and (iii) an intracellular recognition pathway utilizing the cytoplasmic receptors RIG-I/MDA5. Interestingly, these viral recognition pathways converge on TRAF3, which induces interferon through the activation of IRF3 or IRF7 by the TBK-1 and IKKi complexes. While type I IFN has been traditionally associated with antiviral responses, recent studies have demonstrated that many bacteria also induce type I interferon responses. The mechanisms of type I IFN induction and its role in host defense, however, are largely unclear. Studies with the Gram-positive intracellular bacterium Listeria monocytogenes indicated that it may trigger type I IFN induction through novel TLR-independent intracellular receptors and type I IFN may play a detrimental role to host response against listerial infection. In this article, we summarize some of these findings and discuss the functional differences of type I IFNs in bacterial and viral infections.

Keywords

Bacteria interferon TLR TRAF3 virus

References

Dempsey PW , Doyle SE , He JQ , Cheng G. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003; 14: 193—209.

Doyle SE , Vaidya SA , O'Connell R. et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002; 17: 251—263.

Hoebe K. , Du X. , Georgel P. et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003; 424: 743—748.

Yamamoto M. , Sato S. , Hemmi H. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003; 301: 640—643.

Yamamoto M. , Sato S. , Mori K. et al. A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002; 169: 6668—6672.

Fitzgerald KA , McWhirter SM , Faia KL et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003; 4: 491—496.

Hemmi H. , Takeuchi O. , Sato S. et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med 2004; 199: 1641—1650.

McWhirter SM , Fitzgerald KA , Rosains J. , Rowe DC , Golenbock DT , Maniatis T. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci USA 2004; 101: 233—238.

Perry AK , Chow EK , Goodnough JB , Yeh WC , Cheng, G. Differential requirement for TANK-binding kinase-1 in type I interferon responses to Toll-like receptor activation and viral infection. J Exp Med 2004; 199: 1651—1658.

10.

Cheng G. , Baltimore D. TANK, a co-inducer with TRAF2 of TNF- and CD40L-mediated NF-kappaB activation . Genes Dev 1996; 10: 963—973.

11.

Li C. , Ni CZ , Havert ML et al. Downstream regulator TANK binds to the CD40 recognition site on TRAF3. Structure 2002; 10: 403—411.

12.

Oganesyan G. , Saha SK , Guo B. et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2005; 439: 208—211.

13.

Kawai T. , Akira S. TLR signaling. Cell Death Differ 2006 ; 13: 816—825.

14.

Yoneyama M. , Kikuchi M. , Natsukawa T. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5: 730—737.

15.

Yoneyama M. , Kikuchi M. , Matsumoto K. et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005; 75: 2851—2858.

16.

Kawai T. , Takahashi K. , Sato S. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005; 6: 981—988.

17.

Meylan E. , Curran J. , Hofmann K. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005; 437: 1167—1172.

18.

Seth RB , Sun L. , Ea CK , Chen ZJ Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005; 122: 669—682.

19.

Xu L-G. , Wang Y-Y. , Han K-J. et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005; 19: 727—740.

20.

O'Connell RM , Vaidya SA , Perry AK , Saha SK , Demsey PW , Cheng G. Immune activation of type I IFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TNFR-associated NF kappa B kinase-binding kinase 1 . J Immunol 2005; 174: 1602—1607.

21.

O'Connell RM , Saha SK , Vaidya SA et al. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med 2004; 200: 437—445.

22.

Stockinger S. , Materna T. , Stoiber D. et al. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes . J Immunol 2002; 169: 6522—6529.

23.

Auerbuch V. , Brockstedt DG , Meyer-Morse N. et al. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J Exp Med 2004; 200: 527—533.

24.

Carrero JA , Calderon B. , Unanue ER Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J Exp Med 2004; 200: 535—540.

25.

Carrero JA , Calderon B. , Unanue ER Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J Exp Med 2006; doi: 10.1084/jem.20060045.